Bioatla Inc (BCAB) support and resistance · $5.9M cap
Bioatla Inc (BCAB) is a biotechnology company listed on NASDAQ.
This page maps Bioatla Inc (BCAB) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported BCAB revenue for 2023-09-30 was $0. Net income was -$33.3M. BCAB currently screens at market cap $5.9M.
BCAB currently screens at market cap $5.9M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new BCAB 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the BCAB quote page for the session range and the stock page for the full model.
Not investment advice.